BridgeMD
New treatment option for Mild Cognitive Impairment
Official title Multi-modal Large Language Model-Empowered Talk Therapy for Older Adults With ADRD
ClinicalTrials.gov ID: NCT07499570
What this study is testing
- What it's testing
- The purpose of this study is to test the usefulness and the effect of Smart Virtual Reminiscence (SVR) therapy intervention on the Behavioral and Psychological Symptoms of Dementia (BPSD) of patients with Alzheimer's Disease and Related Dementias (ADRD). SVR is designed to help older adults improve their psychological well-being and cognition.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 and older
You may be able to join if
- For the patient:
- age ≥ 65 years
- diagnosis of MCI (mild cognitive impairment) or mild ADRD
- access to a reliable internet connection
- community-dwelling
You likely can't join if
- lives in an assisted living facility or nursing home
- has moderate to severe ADRD as measured by the Quick Dementia Rating System
- has a life expectancy of less than 6 months. For the care partner: Inclusion criteria:
- ≥ 21 years old
- self-identified care partner (e.g., is knowledgeable about the patient's daytime and nighttime behaviors) of a community-dwelling patient diagnosed...
- has MCI or dementia
See the full eligibility criteria
- For the patient:
- age ≥ 65 years
- diagnosis of MCI (mild cognitive impairment) or mild ADRD
- access to a reliable internet connection
- community-dwelling
- elevated behavioral and psychological symptoms of dementia (BPSD), indicated by a HABC (Healthy Aging Brain Care) monitor score above 14 on caregiver report or self report (indicating elevated levels of BPSD)
- presence of one or more specific BPSD behaviors (e.g., agitation, anxiety, depression, apathy, or sleep disturbances)
- ability to consent for themselves.
- lives in an assisted living facility or nursing home
- has moderate to severe ADRD as measured by the Quick Dementia Rating System
- has a life expectancy of less than 6 months. For the care partner: Inclusion criteria:
- ≥ 21 years old
- self-identified care partner (e.g., is knowledgeable about the patient's daytime and nighttime behaviors) of a community-dwelling patient diagnosed with MCI or mild ADRD who will also participate in the study Exclusion...
- has MCI or dementia
- has a severe mental illness or substance abuse
- has a life expectancy of less than 6 months.
The study team makes the final eligibility decision.
Where it's taking place
- Indianapolis, Indiana, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Indianapolis, Indiana, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.